News Daily News CathPCI Model Fails to Capture Excess Bleeding Risk With PCI Plus TAVR Todd Neale December 30, 2020
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Daily News Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5 Michael O'Riordan November 03, 2020
News Daily News Superiority of Ticagrelor Over Clopidogrel in ACS Questioned Todd Neale October 29, 2020
News Daily News Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5 Todd Neale October 09, 2020
News Daily News ‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests Michael O'Riordan September 18, 2020
News Daily News High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention Michael O'Riordan August 11, 2020
News Daily News Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI L.A. McKeown August 10, 2020
News Daily News Reduced-Dose Prasugrel Works Well in Older, Low-Weight ACS Patients Todd Neale July 21, 2020
News Daily News THALES: Ticagrelor Plus Aspirin Cuts Repeat Events After Stroke, TIA Todd Neale July 16, 2020
News Daily News Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis Yael L. Maxwell June 30, 2020
News Daily News TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients L.A. McKeown June 17, 2020
News Daily News Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19 Michael O'Riordan June 08, 2020
News Daily News Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI Yael L. Maxwell June 03, 2020
News Daily News FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention Shelley Wood June 01, 2020
News Daily News P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention Yael L. Maxwell May 15, 2020
News Daily News Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published Michael O'Riordan April 27, 2020
News Daily News How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions Michael O'Riordan April 22, 2020